Abstract
Bcl-2 protein immunoreactivity was examined in 10 pulmonary carcinoid tumors with abundant S-100 protein-positive sustentacular cells (SCs) diagnosed as paraganglioid carcinoids. Its positivity in the mentioned tumors was compared with that of neoplasms formed of neuroendocrine cells only (30 pulmonary carcinoids), and with another group of 30 lesions consisting of neuroendocrine and sustentacular elements, i.e., paragangliomas (11 paragangliomas of the glomus caroticum and 9 jugulotympanic paragangliomas [JPTGs]), pheochromocytomas (5 cases), and a rare form of pulmonary tumorlets (PTUs) with a high frequency of SCs (5 cases). Bcl-2 protein was found in all 70 examined cases, and its expression showed no difference between the examined groups. On the basis of these results, bcl-2 protein expression was not found to be an indicator for either survival or useful for the differential diagnosis of pulmonary carcinoid tumors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
